Clinical trials · Hartford, CT
Clostridioides Difficile Infection clinical trials in Hartford
We’re tracking 3 recruiting clostridioides difficile infection studies with a site in or near Hartford — including Phase 2 and Phase 3 studies, each written for real people, not researchers.
Recruiting studies near Hartford
- NCT06237452RecruitingPhase 3
VE303 to prevent repeat C. diff infections
This trial tests a new medicine called VE303, a live bacterial therapy, to prevent C. diff infections from coming back. It is for people who have had C. diff at least once in the last 6 months, or who are at high risk for a repeat infection due to age or other health problems.
Hartford, ConnecticutAges 12 years+ - NCT07285213RecruitingPhase 2
Preventing C. diff return with an antibody
This study tests a new antibody (AZD5148) to prevent C. diff infection from coming back. If you have a current C. diff infection and are being treated with antibiotics, you may be able to join.
Hamden, ConnecticutAges 18 years+ - NCT07513285RecruitingPhase 2
Ibezapolstat pill for recurrent C. difficile infection
This trial tests a new oral antibiotic called ibezapolstat to treat recurrent C. difficile infection (CDI)—a serious diarrheal illness caused by bacteria in your gut. The study focuses on patients who have had multiple CDI episodes and may benefit from a different treatment approach.
Hamden, ConnecticutAges 18–90
Hear when a new Clostridioides Difficile Infection trial opens near Hartford, CT
We’ll email you when one opens near Hartford, CT — at most once a week, no account needed, unsubscribe anytime.
Clostridioides Difficile Infection trials in other cities
Where these studies are running near Hartford
Institutions with a site for the recruiting clostridioides difficile infection studies listed above.
- Connecticut Clinical Research Institute
- Gastroenterolgy Center of Conneticut
- Hartford Hospital
- Medical Research Center of Connecticut
- Research Site
What taking part in a clostridioides difficile infection study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Looking wider? See all recruiting clostridioides difficile infection studies in Connecticut.
Common questions
- Are there clostridioides difficile infection clinical trials near Hartford?
- Yes. We're currently tracking 3 recruiting clostridioides difficile infection studies with a site near Hartford, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a clostridioides difficile infection study near Hartford?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Hartford to take part?
- Not necessarily. These studies have a site near Hartford, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a clostridioides difficile infection trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New clostridioides difficile infection studies open near Hartford regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.